Brain-tumour clinical-trial endpoints: FDA public workshop.
Nelson
Roxanne
R
D001932:Brain Neoplasms / Q000628:therapy*; D002986:Clinical Trials as Topic; D004493:Education; D023381:Endpoint Determination; D006304:Health Status; D006801:Humans; D017150:Public Sector; D011788:Quality of Life; D016019:Survival Analysis; D014481:United States; D014486:United States Food and Drug Administration